CompletedPhase 3NCT03132116
Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis
Studying Cat-scratch disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Toulouse
- Principal Investigator
- Guillaume MARTIN-BLONDEL, MD, PhDUniversity Hospital of Toulouse, Infectious & Tropical Diseases department
- Intervention
- gentamicin(drug)
- Enrollment
- 75 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2025
Study locations (21)
- Albi Hospital, Albi, France
- Amiens-Picardie Hospital, Amiens, France
- Angers Hospital, Angers, France
- Auch Hospital, Auch, France
- Bordeaux University Hospital, Bordeaux, France
- Cahors Hospital, Cahors, France
- Castres Hospital, Castres, France
- Vendée Hospital, La Roche-sur-Yon, France
- Limoges University Hospital, Limoges, France
- Hospices Civils Lyon, Lyon, France
- Montauban Hospital, Montauban, France
- Montpellier University Hospital, Montpellier, France
- Nîmes University Hospital, Nîmes, France
- Pau Hospital, Pau, France
- Perpignan Hospital, Perpignan, France
- +6 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03132116 on ClinicalTrials.gov